{"id":"https://openalex.org/W2576371571","doi":"https://doi.org/10.1182/blood.v126.23.1280.1280","title":"Translational Focus on Targeting HDAC6 with Ricolinostat Confirms Potent Activity in Preclinical Models of Lymphoma and a Favorable Toxicity Profile in Patients with Relapsed or Refractory Lymphoma","display_name":"Translational Focus on Targeting HDAC6 with Ricolinostat Confirms Potent Activity in Preclinical Models of Lymphoma and a Favorable Toxicity Profile in Patients with Relapsed or Refractory Lymphoma","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2576371571","doi":"https://doi.org/10.1182/blood.v126.23.1280.1280","mag":"2576371571"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.1280.1280","doi":"https://doi.org/10.1182/blood.v126.23.1280.1280","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1280.1280","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer E Amengual","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110497695","display_name":"Renee Lichtenstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lichtenstein Renee","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029806732","display_name":"Celeste Rojas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Celeste Rojas","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058238903","display_name":"Kelly M. Zullo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kelly Zullo","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047947142","display_name":"Maximilian Lombardo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maximilian Lombardo","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113101329","display_name":"Emily Lichtenstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emily Lichtenstein","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031311239","display_name":"Ellen Neylon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ellen Neylon","raw_affiliation_strings":["Center for Lymphoid Malignancies at Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies at Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101491956","display_name":"Changchun Deng","orcid":"https://orcid.org/0000-0001-9372-6086","observed_orcids":["https://orcid.org/0000-0001-9372-6086"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Changchun Deng","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008086243","display_name":"Ahmed Sawas","orcid":"https://orcid.org/0000-0003-2448-0144","observed_orcids":["https://orcid.org/0000-0003-2448-0144"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Sawas","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025137989","display_name":"Bijal Dinesh Shah","orcid":"https://orcid.org/0000-0003-4328-6021","observed_orcids":["https://orcid.org/0000-0003-4328-6021"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bijal D Shah","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078598204","display_name":"Catherine Wheeler","orcid":"https://orcid.org/0000-0001-6528-1702","observed_orcids":["https://orcid.org/0000-0001-6528-1702"]},"institutions":[{"id":"https://openalex.org/I4210146766","display_name":"Acetylon Pharmaceuticals (United States)","ror":"https://ror.org/04re20p56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146766"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Catherine Wheeler","raw_affiliation_strings":["Acetylon Pharmaceuticals, Inc., Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acetylon Pharmaceuticals, Inc., Boston,","institution_ids":["https://openalex.org/I4210146766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103729912","display_name":"Simon S. Jones","orcid":"https://orcid.org/0009-0008-8557-8536","observed_orcids":["https://orcid.org/0009-0008-8557-8536"]},"institutions":[{"id":"https://openalex.org/I4210146766","display_name":"Acetylon Pharmaceuticals (United States)","ror":"https://ror.org/04re20p56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146766"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Simon S Jones","raw_affiliation_strings":["Acetylon Pharmaceuticals, Inc., Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acetylon Pharmaceuticals, Inc., Boston,","institution_ids":["https://openalex.org/I4210146766"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5029806732","https://openalex.org/A5031311239","https://openalex.org/A5047947142","https://openalex.org/A5058238903","https://openalex.org/A5078598204","https://openalex.org/A5103729912","https://openalex.org/A5110497695","https://openalex.org/A5113101329"],"corresponding_institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4210146766"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20011322,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"1280","last_page":"1280"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9409000277519226,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9409000277519226,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.05130000039935112,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ricolinostat","display_name":"ricolinostat","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hdac6-inhibitors","display_name":"HDAC6 inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8769999742507935},{"id":"https://openalex.org/keywords/unfolded-protein-response","display_name":"unfolded protein response","score":0.7799999713897705},{"id":"https://openalex.org/keywords/grp78","display_name":"GRP78","score":0.7699999809265137},{"id":"https://openalex.org/keywords/xbp1","display_name":"XBP1","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.7170000076293945},{"id":"https://openalex.org/keywords/alisertib","display_name":"alisertib","score":0.6949999928474426},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6510000228881836},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.44200000166893005},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.48500001430511475},{"id":"https://openalex.org/keywords/primary-lymphoma","display_name":"primary malignant lymphoma","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6561734676361084},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5993592143058777},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5564572215080261},{"id":"https://openalex.org/C2781462825","wikidata":"https://www.wikidata.org/wiki/Q7363205","display_name":"Romidepsin","level":5,"score":0.5040634870529175},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.4799678325653076},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4462675154209137},{"id":"https://openalex.org/C2780670749","wikidata":"https://www.wikidata.org/wiki/Q14908239","display_name":"Annexin A5","level":4,"score":0.4153793156147003},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.4109947383403778},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32674768567085266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2829056978225708},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24790528416633606},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.23013687133789062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2111225426197052},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.17369449138641357},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.17197903990745544},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.1280.1280","doi":"https://doi.org/10.1182/blood.v126.23.1280.1280","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1280.1280","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980229938","https://openalex.org/W2559152500","https://openalex.org/W2624396871","https://openalex.org/W2597388148","https://openalex.org/W2558147844","https://openalex.org/W3123975871","https://openalex.org/W2556345889","https://openalex.org/W2562330369","https://openalex.org/W2584148742","https://openalex.org/W2336228478"],"abstract_inverted_index":{"Abstract":[0],"Pan-class":[1],"HDAC":[2,571],"inhibitors":[3],"are":[4,13],"active":[5],"agents":[6],"for":[7,324,346,576,630,667,688,771],"select":[8],"subtypes":[9],"of":[10,57,131,161,168,175,181,186,196,215,219,222,260,264,282,330,401,420,485,494,516,530,539,549,579,615,632,636,691,742,762],"lymphoma":[11,72,80,224],"but":[12],"often":[14],"associated":[15],"with":[16,71,98,120,128,156,202,268,279,509,512,544,567,581,603,610,669],"toxicities":[17,437],"such":[18,552],"as":[19,211,213,535,537,553],"fatigue,":[20],"diarrhea/constipation,":[21],"cardiac":[22],"arrhythmias":[23],"and":[24,38,59,92,126,152,170,183,192,232,309,326,343,355,372,388,405,425,446,469,477,522,555,600,624,634],"myelosuppression.":[25],"HDAC6":[26,50],"plays":[27],"a":[28,64,220,247,287,651],"critical":[29],"role":[30],"in":[31,69,78,108,112,266,385,391,639,650,659],"protein":[32,42],"homeostasis":[33],"by":[34,89,166,179,226],"managing":[35],"misfolded":[36,150],"proteins":[37,151],"inducing":[39],"the":[40,54,61,109,145,162,197,216,258,339,392,402,406,413,455,490,563,577,590,598,620,637,689],"unfolded":[41],"response":[43],"(UPR).":[44],"Ricolinostat":[45,95,116,606,684],"is":[46,107,562,607,685],"an":[47,241,528,568,640,739,759],"isoform":[48,569],"selective":[49,570],"inhibitor.":[51],"We":[52,655],"evaluated":[53,77,345,629,649],"preclinical":[55,644],"effects":[56,596],"ricolinostat":[58,143,157,203,265,284,593,658],"translated":[60],"findings":[62],"into":[63],"multicenter":[65],"Phase":[66,249],"1b":[67],"study":[68,254,257,342,456],"patients":[70,267,300,313,335,382,390,480,580,616,668],"(NCT":[73],"02091063).":[74],"Cytotoxicity":[75],"was":[76,177,274,351,410,423],"16":[79],"cell":[81,199],"lines":[82,515],"(8":[83],"DBCL,":[84],"4":[85,87],"MCL,":[86],"TCL)":[88],"Cell":[90],"TiterGlo":[91],"Annexin":[93],"V.":[94],"has":[96],"activity":[97],"IC50":[99],"values":[100],"ranging":[101],"from":[102,427],"0.9-4.7":[103],"uM":[104],"range,":[105],"which":[106,472],"range":[110],"observed":[111,504],"clinical":[113],"PK":[114,325,623],"studies.":[115],"displayed":[117],"marked":[118],"synergy":[119,129],"bortezomib,":[121],"PI3K":[122],"inhibitors,":[123],"disatinib,":[124],"alisertib,":[125],"ibrutinib":[127],"coeficients":[130],"0.24,":[132],"0.29,":[133],"0.64,":[134],"0.07,":[135],"0.16":[136],"respectively":[137],"(values<1":[138],"imply":[139],"synergy).":[140],"In":[141,240],"vitro":[142],"modulates":[144],"UPR":[146,176,599,638],"leading":[147],"to":[148,159,209,236,243,256,295,316,451,454,505,527,573,642,664],"accumulated":[149],"ultimately":[153],"apoptosis.":[154],"Treatment":[155],"led":[158],"inhibition":[160],"aggresome":[163],"pathway":[164],"evidenced":[165],"acetylation":[167,180,631],"a-tubulin":[169],"increased":[171,188,229],"poly-ubiquitinated":[172],"proteins.":[173],"Upregulation":[174],"demonstrated":[178,204],"GRP78":[182,231],"subsequent":[184],"dissociation":[185],"PERK,":[187],"p-eIF2a,":[189],"spliced":[190],"XBP-1":[191,233],"CHOP.":[193],"Xenograft":[194],"studies":[195,588],"OCI-Ly10":[198],"line":[200],"treated":[201,278,488],"significantly":[205],"prolonged":[206],"survival":[207],"compared":[208,235],"control,":[210],"well":[212,536,608],"modulation":[214,635],"UPR.":[217],"Evaluation":[218],"collection":[221],"primary":[223],"samples":[225],"IHC":[227],"revealed":[228],"HDAC6,":[230],"expression":[234],"reactive":[237],"lymphoid":[238,272,585,671],"tissue.":[239],"effort":[242,641],"translate":[244],"these":[245],"findings,":[246],"multi-center":[248],"Ib":[250,341],"open-label,":[251],"single":[252,304],"agent":[253],"designed":[255],"safety":[259,311],"2":[261,296,424],"dose":[262,297,409],"schedules":[263],"relapsed":[269,582,670],"or":[270,499,583,744,764],"refractory":[271,510,584],"malignancies":[273],"initiated.":[275],"Patients":[276,291],"were":[277,292,301,314,322,336,344,358,383,396,439,473,487],"160":[280],"mg":[281],"oral":[283],"continuously":[285],"on":[286,303,338,412,489,619,738,758],"28":[288],"day":[289],"cycle.":[290],"accrued":[293],"sequentially":[294],"cohorts:":[298],"3":[299,436],"enrolled":[302,315,337,384],"daily":[305,318],"dosing":[306,319,387,403,415],"(QD)":[307],"schedule,":[308],"following":[310],"assessment,":[312],"twice":[317],"(BID).":[320],"Samples":[321],"collected":[323],"PD":[327,625],"analysis.":[328],"As":[329],"July":[331],"25th":[332],"2015,":[333],"11":[334],"phase":[340,652],"safety.":[347],"The":[348,417,433],"median":[349,418],"age":[350],"36":[352],"yrs":[353],"(24-86)":[354],"7":[356],"(64%)":[357],"male.":[359],"Sixty-four":[360],"percent":[361,614],"had":[362,523,546],"5":[363],"prior":[364,514],"treatments":[365],"(range:":[366],"1-15).":[367],"Histologies":[368],"included":[369,462],"HL":[370,511],"(N=3)":[371],"NHL":[373],"(N=8)":[374],"including":[375],"DLBCL=3,":[376],"MZL=2,":[377],"FL=1,":[378],"PTCL=1,":[379],"PTLD=1.":[380],"Three":[381,479],"QD":[386,559],"8":[389],"BID":[393,414,491,621],"schedule.":[394,416,622],"There":[395],"no":[397,497,611],"DLTs":[398],"at":[399],"either":[400],"schedules,":[404],"maximum":[407],"administrable":[408],"determined":[411],"number":[419],"cycles":[421],"completed":[422],"ranged":[426],"1":[428,476],"through":[429,597],"12+":[430],"(currently":[431],"ongoing).":[432],"only":[434],"grade":[435,475],"reported":[438,565],"anemia":[440],"(27%),":[441],"hyponatremia":[442],"(9%),":[443,448],"hypercalcemia":[444],"(9%)":[445],"hypotension":[447],"none":[449],"thought":[450],"be":[452,574,628,648],"attributed":[453],"drug.":[457],"Other":[458],"treatment":[459,578,666,690],"emergent":[460],"events":[461],"nausea":[463],"(45%),":[464],"diarrhea":[465],"(36%),":[466],"fatigue":[467],"(36%)":[468],"vomiting":[470],"(27%)":[471],"all":[474,484],"2.":[478],"achieved":[481,518,617],"stable":[482,519],"disease,":[483],"whom":[486],"schedule":[492],"(3":[493],"8,":[495],"37.5%),":[496],"complete":[498],"partial":[500],"responses":[501],"have":[502],"been":[503],"date.":[506],"One":[507],"patient":[508,543],"14":[513],"therapy":[517],"disease":[520],"(SD)":[521],"symptomatic":[524],"improvement":[525],"corresponding":[526],"increase":[529],"hemoglobin":[531],"after":[532,557],"9":[533],"cycles,":[534],"resolution":[538,548],"B":[540,550],"symptoms.":[541],"Another":[542],"PTCL":[545],"immediate":[547],"symptoms":[551],"fevers":[554],"pruritus":[556],"starting":[558],"dosing.":[560],"This":[561],"first":[564],"experience":[566],"inhibitor":[572],"studied":[575,687],"malignancies.":[586,672],"Preclinical":[587],"support":[589],"notion":[591],"that":[592,657],"mediates":[594],"its":[595],"potently":[601],"synergizes":[602],"complementary":[604],"agents.":[605],"tolerated":[609],"DLTs.":[612],"Thirty-seven":[613],"SD":[618],"data":[626],"will":[627,647,662],"alpha-tubulin":[633],"confirm":[643],"findings.":[645],"Efficacy":[646],"II":[653],"study.":[654],"believe":[656],"rational":[660],"combinations":[661],"lead":[663],"effective":[665],"Disclosures":[673],"Amengual:":[674],"Acetylon":[675,734,822],"Pharmaceuticals,":[676,735,784,788,823],"INC:":[677,736,785,824],"Consultancy,":[678,756,795,801,806,814,820,827],"Research":[679,708,711,714,718,732,774,778,797,803,807,829],"Funding.":[680,715,830],"Off":[681],"Label":[682],"Use:":[683],"being":[686],"lymphoma.":[692],"Neylon:Seattle":[693],"Genetics:":[694,717,777,817],"Speakers":[695,698,701,704,724,751,767,781],"Bureau;":[696,699,702,725,752,768],"Celgene:":[697,755,805],"Genentech:":[700],"Gilead:":[703,710],"Bureau.":[705,782],"Deng:TG":[706],"Therapeutics:":[707],"Funding;":[709,712,719,733,775,779,798,804,808],"Amgen/Onyx:":[713],"Sawas:Seattle":[716],"Gilead":[720],"Sciences:":[721],"Honoraria.":[722],"Shah:Pharmacyclics:":[723],"NCCN:":[726],"Consultancy;":[727,729,812,818,825],"SWOG:":[728],"Rosetta":[730],"Genomics:":[731],"Membership":[737,757],"entity's":[740,760],"Board":[741,761],"Directors":[743,763],"advisory":[745,765],"committees;":[746],"Plexus":[747],"Communications:":[748],"Honoraria;":[749,754,815,821],"Spectrum:":[750],"Bayer:":[753,819],"committees,":[766],"DeBartolo":[769],"Institute":[770],"Personlaized":[772],"Medicine:":[773],"Seattle":[776,816],"Janssen:":[780],"Wheeler:Acetylon":[783],"Employment.":[786],"Jones:Acetylon":[787],"Inc.:":[789],"Employment,":[790],"Equity":[791],"Ownership.":[792],"O'Connor:Spectrum":[793],"Pharmaceuticals:":[794],"Honoraria,":[796,802,828],"Takeda":[799],"Millennium:":[800],"Bristol-Myers":[809],"Squibb":[810],"Company:":[811],"Novartis:":[813],"Mundipharma:":[826]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-26T00:00:00"}